肠道菌群及免疫调节与儿童哮喘关系的研究进展

doi:10.12114/j.issn.1007-9572.2021.01.045

摘要/Abstract

摘要： 支气管哮喘（以下简称哮喘）是一种常见的慢性呼吸系统疾病，严重威胁人类健康。迄今为止，全球约有3亿多人患有哮喘，其中儿童居多。流行病学调查研究显示，我国0~14岁儿童哮喘患病率为2.32%，且呈明显上升趋势。对于儿童而言，免疫系统发育不全且肠道菌群正处于生理性演替过程，极容易发生肠道菌群失调，导致肠黏膜屏障的破坏以及局部免疫失调，进而严重影响儿童哮喘的发生发展。本文将论述儿童哮喘发生、发展的免疫调节作用机制与肠道微生物的关系，并基于肠道菌群探讨干预措施，为哮喘的治疗提供新思路。

关键词: 哮喘, 胃肠道微生物组, 儿童, 免疫调节, 综述

Abstract:

Bronchial asthma, commonly known as asthma, is a frequently seen chronic respiratory disease that seriously threatens human health. More than 300 million people have had asthma worldwide, and most of them are children. Epidemiological investigations have shown that the prevalence of asthma among Chinese children aged 0-14 is 2.32%, and it is increasing year by year. Children are more prone to gut flora imbalance due to underdeveloped immune system, and physiologically successional changing of gut flora, which leads to the destruction of the intestinal mucosal barrier and local immune imbalance, eventually causing the development of asthma. We reviewed the latest advances in the immune regulatory mechanism of childhood asthma, and its association with gut microbiota, as well as interventions targeting gut microbiota, providing new ideas for the treatment of childhood asthma.

Key words: Asthma, Gastrointestinal microbiome, Child, Immunomodulation, Review

中图分类号:

R562.25

崔天怡,刘佳蕊,吕彬,等. 肠道菌群及免疫调节与儿童哮喘关系的研究进展[J]. 中国全科医学, 2022, 25(08): 1021-1026. DOI: 10.12114/j.issn.1007-9572.2021.01.045.

CUI Tianyi, LIU Jiarui, LYU Bin, GAO Xiumei, ZHAO Xin.

Novel Developments in the Relationship of Gut Microbiota and Immune Regulation with Childhood Asthma [J]. Chinese General Practice, 2022, 25(08): 1021-1026.

图/表 1

参考文献 73

[1]	HAMMAD H, LAMBRECHT B N. The basic immunology of asthma[J]. Cell，2021，184(6):1469-1485. DOI：10.1016/j.cell.2021.02.016.
[2]	中华医学会儿科学会呼吸学组，《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南[J]. 中华儿科杂志，2008，46(10):745-753. DOI：10.3321/j.issn:0578-1310.2008.10.006.
[3]	PLUNKETT C H, NAGLER C R. The influence of the microbiome on allergic sensitization to food[J]. J Immunol，2017，198(2):581-589. DOI：10.4049/jimmunol.1601266.
[4]	ARRIETA M C, STIEMSMA L T, DIMITRIU P A，et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma[J]. Sci Transl Med，2015，7(307):307ra152. DOI：10.1126/scitranslmed.aab2271.
[5]	CESTA M F. Normal structure，function，and histology of mucosa-associated lymphoid tissue[J]. Toxicol Pathol，2006，34(5):599-608. DOI：10.1080/01926230600865531.
[6]	CHARLSON E S, DIAMOND J M, BITTINGER K，et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant[J]. Am J Respir Crit Care Med，2012，186(6):536-545. DOI：10.1164/rccm.201204-0693OC.
[7]	KAYAMA H, OKUMURA R, TAKEDA K. Interaction between the microbiota，epithelia，and immune cells in the intestine[J]. Annu Rev Immunol，2020，38:23-48. DOI：10.1146/annurev-immunol-070119-115104.
[8]	KLOSE C S, ARTIS D. Innate lymphoid cells as regulators of immunity，inflammation and tissue homeostasis[J]. Nat Immunol，2016，17(7):765-774. DOI：10.1038/ni.3489.
[9]	JOERIS T, MÜLLER-LUDA K, AGACE W W，et al. Diversity and functions of intestinal mononuclear phagocytes[J]. Mucosal Immunol，2017，10(4):845-864. DOI：10.1038/mi.2017.22.
[10]	SODERHOLM A T, PEDICORD V A. Intestinal epithelial cells：at the interface of the microbiota and mucosal immunity[J]. Immunology，2019，158(4):267-280. DOI：10.1111/imm.13117.
[11]	ALLAM-NDOUL B, CASTONGUAY-PARADIS S, VEILLEUX A. Gut microbiota and intestinal trans-epithelial permeability[J]. Int J Mol Sci，2020，21(17):E6402. DOI：10.3390/ijms21176402.
[12]	LONG H Y. Esculetin attenuates Th2 and Th17 responses in an ovalbumin-induced asthmatic mouse model[J]. Inflammation，2016，39(2):735-743. DOI：10.1007/s10753-015-0300-4.
[13]	SACKS D, BAXTER B, CAMPBELL B C V，et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke [J]. Int J Stroke，2018，13(6):612-632. DOI：10.1177/1747493018778713.
[14]	LINHART B, FREIDL R, ELISYUTINA O，et al. Molecular approaches for diagnosis，therapy and prevention of cow's milk allergy[J]. Nutrients，2019，11(7):E1492. DOI：10.3390/nu11071492.
[15]	WANG S J, SHARKEY K A, MCKAY D M. Modulation of the immune response by helminths：a role for serotonin?[J]. Biosci Rep，2018，38(5):BSR20180027. DOI：10.1042/BSR20180027.
[16]	CHIGBU D I, LOONAWAT R, SEHGAL M，et al. Hepatitis C virus infection：Host-Virus interaction and mechanisms of viral persistence[J]. Cells，2019，8(4):E376. DOI：10.3390/cells8040376.
[17]	IVANOV I I, ATARASHI K, MANEL N，et al. Induction of intestinal Th17 cells by segmented filamentous bacteria[J]. Cell，2009，139(3):485-498. DOI：10.1016/j.cell.2009.09.033.
[18]	ATARASHI K, TANOUE T, SHIMA T，et al. Induction of colonic regulatory T cells by indigenous Clostridium species[J]. Science，2011，331(6015):337-341. DOI：10.1126/science.1198469.
[19]	MAZMANIAN S K, LIU C H, TZIANABOS A O，et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system[J]. Cell，2005，122(1):107-118. DOI：10.1016/j.cell.2005.05.007.
[20]	ELENIUS V, PALOMARES O, WARIS M，et al. The relationship of serum vitamins A，D，E and LL-37 levels with allergic status，tonsillar virus detection and immune response[J]. PLoS One，2017，12(2):e0172350. DOI：10.1371/journal.pone.0172350.
[21]	GAUVREAU G M, O'BYRNE P M, BOULET L P，et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses[J]. N Engl J Med，2014，370(22):2102-2110. DOI：10.1056/nejmoa1402895.
[22]	WYPYCH T P, PATTARONI C, PERDIJK O，et al. Microbial metabolism of L-tyrosine protects against allergic airway inflammation[J]. Nat Immunol，2021，22(3):279-286. DOI：10.1038/s41590-020-00856-3.
[23]	BOONPIYATHAD T, SÖZENER Z C, SATITSUKSANOA P，et al. Immunologic mechanisms in asthma[J]. Semin Immunol，2019，46:101333. DOI：10.1016/j.smim.2019.101333.
[24]	WALKER J A, MCKENZIE A N J. TH2 cell development and function[J]. Nat Rev Immunol，2018，18(2):121-133. DOI：10.1038/nri.2017.118.
[25]	GON Y, HASHIMOTO S. Role of airway epithelial barrier dysfunction in pathogenesis of asthma[J]. Allergol Int，2018，67(1):12-17. DOI：10.1016/j.alit.2017.08.011.
[26]	HUANG Y F, MAO K R, CHEN X，et al. S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense[J]. Science，2018，359(6371):114-119. DOI：10.1126/science.aam5809.
[27]	GASTEIGER G, FAN X Y, DIKIY S，et al. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs[J]. Science，2015，350(6263):981-985. DOI：10.1126/science.aac9593.
[28]	GRAY J, OEHRLE K, WORTHEN G，et al. Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection[J]. Sci Transl Med，2017，9(376):eaaf9412. DOI：10.1126/scitranslmed.aaf9412.
[29]	BRADLEY C P, TENG F, FELIX K M，et al. Segmented filamentous bacteria provoke lung autoimmunity by inducing gut-lung axis Th17 cells expressing dual TCRs[J]. Cell Host Microbe，2017，22(5):697-704.e4. DOI：10.1016/j.chom.2017.10.007.
[30]	ICHINOHE T, PANG I K, KUMAMOTO Y，et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection[J]. Proc Natl Acad Sci USA，2011，108(13):5354-5359. DOI：10.1073/pnas.1019378108.
[31]	QIAN G J, JIANG W, ZOU B K，et al. LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma[J]. J Exp Med，2018，215(9):2397-2412. DOI：10.1084/jem.20172225.
[32]	ANAND S, MANDE S S. Diet，microbiota and gut-lung connection[J]. Front Microbiol，2018，9:2147. DOI：10.3389/fmicb.2018.02147.
[33]	BLAAK E E, CANFORA E E, THEIS S，et al. Short chain fatty acids in human gut and metabolic health[J]. Benef Microbes，2020，11(5):411-455. DOI：10.3920/BM2020.0057.
[34]	RODUIT C, FREI R, FERSTL R，et al. High levels of butyrate and propionate in early life are associated with protection against atopy[J]. Allergy，2019，74(4):799-809. DOI：10.1111/all.13660.
[35]	TROMPETTE A, GOLLWITZER E S, YADAVA K，et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis[J]. Nat Med，2014，20(2):159-166. DOI：10.1038/nm.3444.
[36]	CAIT A, HUGHES M R, ANTIGNANO F，et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids[J]. Mucosal Immunol，2018，11(3):785-795. DOI：10.1038/mi.2017.75.
[37]	SUN L C, FU J R, LIN S H，et al. Particulate matter of 2.5 μm or less in diameter disturbs the balance of TH17/regulatory T cells by targeting glutamate oxaloacetate transaminase 1 and hypoxia-inducible factor 1α in an asthma model[J]. J Allergy Clin Immunol，2020，145(1):402-414. DOI：10.1016/j.jaci.2019.10.008.
[38]	HUFFNAGLE G B, DICKSON R P, LUKACS N W. The respiratory tract microbiome and lung inflammation：a two-way street[J]. Mucosal Immunol，2017，10(2):299-306. DOI：10.1038/mi.2016.108.
[39]	SZE M A, TSURUTA M, YANG S W，et al. Changes in the bacterial microbiota in gut，blood，and lungs following acute LPS instillation into mice lungs[J]. PLoS One，2014，9(10):e111228. DOI：10.1371/journal.pone.0111228.
[40]	PERRONE E E, JUNG E, BREED E，et al. Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis[J]. Shock，2012，38(1):68-75. DOI：10.1097/SHK.0b013e318259abdb.
[41]	YOUNG R P, HOPKINS R J, MARSLAND B. The gut-liver-lung axis. modulation of the innate immune response and its possible role in chronic obstructive pulmonary disease[J]. Am J Respir Cell Mol Biol，2016，54(2):161-169. DOI：10.1165/rcmb.2015-0250PS.
[42]	KISS E A, VONARBOURG C, KOPFMANN S，et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles[J]. Science，2011，334(6062):1561-1565. DOI：10.1126/science.1214914.
[43]	SINGH N, GURAV A, SIVAPRAKASAM S，et al. Activation of Gpr109a，receptor for niacin and the commensal metabolite butyrate，suppresses colonic inflammation and carcinogenesis[J]. Immunity，2014，40(1):128-139. DOI：10.1016/j.immuni.2013.12.007.
[44]	KIBE R, KURIHARA S, SAKAI Y，et al. Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice[J]. Sci Rep，2014，4:4548. DOI：10.1038/srep04548.
[45]	GEIGER R, RIECKMANN J C, WOLF T，et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity[J]. Cell，2016，167(3):829-842.e13. DOI：10.1016/j.cell.2016.09.031.
[46]	ESLAMI M, BAHAR A, KEIKHA M，et al. Probiotics function and modulation of the immune system in allergic diseases[J]. Allergol Immunopathol （Madr），2020，48(6):771-788. DOI：10.1016/j.aller.2020.04.005.
[47]	CHIU C J, HUANG M T. Asthma in the precision medicine era：biologics and probiotics[J]. Int J Mol Sci，2021，22(9):4528. DOI：10.3390/ijms22094528.
[48]	WEI X C, JIANG P, LIU J B，et al. Association between probiotic supplementation and asthma incidence in infants：a meta-analysis of randomized controlled trials[J]. J Asthma，2020，57(2):167-178. DOI：10.1080/02770903.2018.1561893.
[49]	GORISSEN D M W, RUTTEN N B M M, OOSTERMEIJER C M J，et al. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda study[J]. Clin Exp Allergy，2014，44(11):1431-1433. DOI：10.1111/cea.12413.
[50]	NIERS L E M, TIMMERMAN H M, RIJKERS G T，et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines[J]. Clin Exp Allergy，2005，35(11):1481-1489. DOI：10.1111/j.1365-2222.2005.02375.x.
[51]	NIERS L E, HOEKSTRA M O, TIMMERMAN H M，et al. Selection of probiotic bacteria for prevention of allergic diseases：immunomodulation of neonatal dendritic cells[J]. Clin Exp Immunol，2007，149(2):344-352. DOI：10.1111/j.1365-2249.2007.03421.x.
[52]	AZAD M B, CONEYS J G, KOZYRSKYJ A L，et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze：systematic review and meta-analysis[J]. BMJ，2013，347:f6471. DOI：10.1136/bmj.f6471.
[53]	WICKENS K, STANLEY T V, MITCHELL E A，et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years：does it also reduce atopic sensitization?[J]. Clin Exp Allergy，2013，43(9):1048-1057. DOI：10.1111/cea.12154.
[54]	KALLIOMÄKI M, SALMINEN S, POUSSA T，et al. Probiotics during the first 7 years of life：a cumulative risk reduction of eczema in a randomized，placebo-controlled trial[J]. J Allergy Clin Immunol，2007，119(4):1019-1021. DOI：10.1016/j.jaci.2006.12.608.
[55]	KUITUNEN M, KUKKONEN K, JUNTUNEN-BACKMAN K，et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort[J]. J Allergy Clin Immunol，2009，123(2):335-341. DOI：10.1016/j.jaci.2008.11.019.
[56]	BOYLE R J, ISMAIL I H, KIVIVUORI S，et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema：a randomized controlled trial[J]. Allergy，2011，66(4):509-516. DOI：10.1111/j.1398-9995.2010.02507.x.
[57]	WEST C E, HAMMARSTRÖM M L, HERNELL O. Probiotics in primary prevention of allergic disease-follow-up at 8-9 years of age[J]. Allergy，2013，68(8):1015-1020. DOI：10.1111/all.12191.
[58]	ABRAHAMSSON T R, JAKOBSSON T, BJÖRKSTÉN B，et al. No effect of probiotics on respiratory allergies：a seven-year follow-up of a randomized controlled trial in infancy[J]. Pediatr Allergy Immunol，2013，24(6):556-561. DOI：10.1111/pai.12104.
[59]	KAUPPI P, KUOKKA NEN M, KUKKONEN K，et al. Interaction of NPSR1 genotypes and probiotics in the manifestation of atopic eczema in early childhood[J]. Allergol Immunopathol（Madr），2014，42(6):560-567. DOI：10.1016/j.aller.2013.10.001.
[60]	LOO E X L, LLANORA G V, LU Q S，et al. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants：a 5-year follow-up[J]. Int Arch Allergy Immunol，2014，163(1):25-28. DOI：10.1159/000356338.
[61]	BERNI CANANI R, DI COSTANZO M, BEDOGNI G，et al. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy：3-year randomized controlled trial[J]. J Allergy Clin Immunol，2017，139(6):1906-1913.e4. DOI：10.1016/j.jaci.2016.10.050.
[62]	CABANA M D, MCKEAN M, CAUGHEY A B，et al. Early probiotic supplementation for eczema and asthma prevention：a randomized controlled trial[J]. Pediatrics，2017，140(3):e20163000. DOI：10.1542/peds.2016-3000.
[63]	FELESZKO W, JAWORSKA J, RHA R D，et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma[J]. Clin Exp Allergy，2007，37(4):498-505. DOI：10.1111/j.1365-2222.2006.02629.x.
[64]	SPACOVA I, VAN BEECK W, SEYS S，et al. Lactobacillus rhamnosus probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model[J]. Gut Microbes，2020，11(6):1729-1744. DOI：10.1080/19490976.2020.1766345.
[65]	KARIMI K, INMAN M D, BIENENSTOCK J，et al. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice[J]. Am J Respir Crit Care Med，2009，179(3):186-193. DOI：10.1164/rccm.200806-951OC.
[66]	WANG X F, HUI Y, ZHAO L，et al. Oral administration of Lactobacillus paracasei L9 attenuates PM2.5-induced enhancement of airway hyperresponsiveness and allergic airway response in murine model of asthma[J]. PLoS One，2017，12(2):e0171721. DOI：10.1371/journal.pone.0171721.
[67]	KAWAHARA T, TAKAHASHI T, OISHI K，et al. Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model[J]. Microbiol Immunol，2015，59(1):1-12. DOI：10.1111/1348-0421.12210.
[68]	WU C T, CHEN P J, LEE Y T，et al. Effects of immunomodulatory supplementation with Lactobacillus rhamnosus on airway inflammation in a mouse asthma model[J]. J Microbiol Immunol Infect，2016，49(5):625-635. DOI：10.1016/j.jmii.2014.08.001.
[69]	CERVANTES-GARCÍA D, JIMÉNEZ M, RIVAS-SANTIAGO C E，et al. Lactococcus lactis NZ9000 prevents asthmatic airway inflammation and remodelling in rats through the improvement of intestinal barrier function and systemic TGF-β production[J]. Int Arch Allergy Immunol，2021，182(4):277-291. DOI：10.1159/000511146.
[70]	RACEDO S, VILLENA J, MEDINA M，et al. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice[J]. Microbes Infect，2006，8(9/10):2359-2366. DOI：10.1016/j.micinf.2006.04.022.
[71]	HORI T, KIYOSHIMA J, SHIDA K，et al. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota[J]. Clin Diagn Lab Immunol，2002，9(1):105-108. DOI：10.1128/cdli.9.1.105-108.2002.
[72]	TAKEDA S, TAKESHITA M, KIKUCHI Y，et al. Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice：alleviation of influenza infection by its immunomodulatory activity through intestinal immunity[J]. Int Immunopharmacol，2011，11(12):1976-1983. DOI：10.1016/j.intimp.2011.08.007.
[73]	ZELAYA H, TADA A, VIZOSO-PINTO M G，et al. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage[J]. Inflamm Res，2015，64(8):589-602. DOI：10.1007/s00011-015-0837-6.